Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glucose Intolerance clinical trials
Every US clinical trial registered for Glucose Intolerance — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
15 US clinical trials · 6 currently recruiting
The research picture
Glucose Intolerance has 15 registered US clinical trials, 6 of them open to new participants right now — about 40% of the total.
- 6
- recruiting participants now
- 40%
- of trials open to enrollment
- 1
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Signos
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Rare and Atypical Diabetes Network
University of South Florida
NCT05544266
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
Old Dominion University
NCT05468255
Time to Move in Pregnancy Hyperglycemia
The University of Tennessee, Knoxville
NCT06125704
The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU
Massachusetts General Hospital
NCT04737200
Sleep and Metabolism
Oregon Health and Science University
NCT05775627
The Acute T-Rex (Timing of Resistance Exercise) Study
University of Utah
NCT06366399
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Signos
NCT05121844
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Signos
NCT05874635
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
University of North Carolina, Chapel Hill
NCT00067587
Glucose Risk Assessment in Employer Populations
DexCom
NCT04529824
Almond Consumption and Glycemia
Purdue University
NCT03236116
A Trial of Tadalafil and Glycemic Traits
Thomas J. Wang, MD
NCT01444651
Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population
Leryn Reynolds
NCT04812392
Daily Vinegar Ingestion and 24-Hour Blood Glucose Control
Arizona State University
NCT06319443
Postpartum Weight Loss and Exercise (PRIDE)
Pennington Biomedical Research Center
NCT01296516
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Glucose Intolerance Trial Landscape
ClinicalTrials.gov lists 15 US studies indexed under Glucose Intolerance, and 6 of those are currently open to recruitment — roughly 40% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Glucose Intolerance shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 0 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Glucose Intolerance is led by Signos with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 15 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Glucose Intolerance?
PlainTrial tracks 15 US clinical trials for Glucose Intolerance, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Glucose Intolerance?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.